News | August 10, 2021
ALS drug RADICAVA holds promise as it completes four years in US
Nearly 6,000 patients have been treated with the drug since 2017
Nearly 6,000 patients have been treated with the drug since 2017
Founded in 2019, the start-up develops digital therapeutics, a therapeutic intervention from the convergence of biology and information technology
By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
Five seats reserved for Wards of COVID warriors in central MBBS admission
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
The shareholders have also ratified the Board’s approval to allot 10 lakhs warrants to the Promoter, Managing Director and CEO, Mark Saldanha at the said price of Rs. 74 per warrant
The roller coaster ride during the pandemic has taken Indian pharmaceutical industry through a lot of bitter sweet experiences.
The U.S. Development Finance Corporation is funding a substantial expansion of manufacturing capability for BioE, the vaccine manufacturer in India
Subscribe To Our Newsletter & Stay Updated
